BIODEXA PHARMACEUTICALS LIMITED – Trademark Portfolio

Entity Type: 99

BIODEXA PHARMACEUTICALS LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BIODEXA.

1 Caspian Point,

Caspian Way Cardiff CF10 4DQ

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BIODEXA
BIODEXA
Registered 2023

Trademark Classifications

BIODEXA PHARMACEUTICALS LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does BIODEXA PHARMACEUTICALS LIMITED have?

BIODEXA PHARMACEUTICALS LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does BIODEXA PHARMACEUTICALS LIMITED file in?

BIODEXA PHARMACEUTICALS LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.

What are BIODEXA PHARMACEUTICALS LIMITED's most well-known trademarks?

BIODEXA PHARMACEUTICALS LIMITED's registered trademark portfolio includes well-known marks such as BIODEXA. These are among 1 currently registered trademark in the portfolio.

What is BIODEXA PHARMACEUTICALS LIMITED's trademark registration success rate?

BIODEXA PHARMACEUTICALS LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.